Healthcare Services Group (HCSG) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
23 Oct, 2026Executive summary
Q3 revenue rose 3.3% YoY to $479.6 million; net income declined 42.1% to $24.9 million, reflecting prior-year ERC benefits and lower investment income.
New client wins, retention and operational execution supported a ninth sequential revenue increase in the past 10 quarters.
NEXDINE expands senior living and hospitality capabilities; management expects >$150 million in annual revenue at comparable margins and immediate EPS accretion.
Financial highlights
Q3 diluted EPS was $0.36 vs. $0.59; operating income was $31.9 million vs. $45.9 million.
Q3 costs of services were $399.2 million, or 83.2% of revenue; SG&A was $48.5 million reported and $49.1 million adjusted for deferred compensation, or 10.2% of revenue.
Nine-month revenue increased to $1.413 billion from $1.370 billion; net income was $73.6 million vs. $27.8 million and diluted EPS was $1.05 vs. $0.38.
Q3 operating cash flow was $30.2 million; excluding a $9.5 million payroll-accrual change, it was $20.7 million.
Outlook and guidance
Q4 revenue guidance is $535 million-$545 million; 2027 revenue growth guidance rose from mid-single digits to low double digits, including mid-single-digit organic growth and NEXDINE.
Full-year 2026 effective tax rate is expected to be ~25%.
2026 capital expenditures were estimated at $5.0 million-$7.0 million; $5.1 million had been spent through September 30.
Growth priorities include customer wins and retention, contractual price increases, cost efficiencies and developing managerial talent.
Latest events from Healthcare Services Group
- Q2 revenue reached $470.8M with margin gains, strong cash flow, and active share repurchases.HCSG
Q2 2026 - Dominates outsourced healthcare services with strong growth, financials, and client retention.HCSG
Investor presentation - Q1 2026 saw 3.4% revenue growth, 51% higher net income, and robust share repurchases.HCSG
Q1 2026 - Shareholders to vote on directors, pay, auditor, and equity plan amid strong growth and governance.HCSG
Proxy filing - Revenue up 7.1% to $1.84B, net income $59.1M, new $75M buyback, 2026 growth outlook positive.HCSG
Q4 2025 - Q3 revenue up 8.5% to $464.3M, net income $43M, aided by ERC refunds and strong segment growth.HCSG
Q3 2025 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 2024 - Q2 revenue rose 1.8% to $426.3M, but bad debt charges led to a net loss of $1.8M.HCSG
Q2 2024 - Q1 2025 saw record revenue, higher net income, and raised cash flow guidance.HCSG
Q1 2025